Crystallization Test for Early Detection of Malignancy

  • Sangeeta Bali Associate Professor, Department of Anatomy, Major S.D. Singh Medical College & Hospital, Fatehgarh, Farrukhabad, Uttar Pradesh, India
  • R. R. Marathe Professor, Department of Anatomy, Dr. R. R. Kambe Dental College & Hospital, Kanheri, Sarap, Akola, Maharashtra, India
Keywords: Crystallisation, Cupric Chloride, Malignancy, Benign, Blood, Cancer.


Background:  Cancer can involve any tissue of the body. In most of the cases, patients present themselves to a medical facility when the disease has reached an advanced stage and is not amenable to treatment. So, the line of action in order to cure cancer should be its early detection and prompt treatment of precancerous lesions. This is one of the cornerstones of cancer prevention.  Aim: Aim of the study was to determine the efficiency of crystallisation test for early detection of malignancy. Methods:  110 subjects were included in the present study. 50 subjects were normal comprising the control group and 60 subjects were diagnosed with dysplastic changes. All samples are collected by finger prick with aseptic precautions. Crystallization tests were carried out strictly maintaining all necessary conditions. The results obtained were than analysed and studied. Results: Crystallization pattern with only cupric chloride solution alone is very haphazard and completely lacking of co-ordination. The pattern of admixture of normal blood solution and cupric chloride is typical and shows co-coordinated arrangement of crystals. Blood crystallization pattern in control group shows very specific arrangement of needle like crystals of cupric chloride. Hollow Glans formation characterizes the benign condition while hollow glans along with gap star formation characterizes the precancerous conditions. Present study of malignant pattern proves that transverse bar or transverse formation is confirmatory finding in advanced cases. Conclusions: Inference of the test shows that control group had shown 100% positivity while all cases of malignant as well as premalignant conditions was shown 99% positivity. 


Download data is not yet available.


1. Kastenbaum R. Theories of human aging: The search for a conceptual framework. Journal of Social Issues. 1965 Oct 1;21(4):13-36.
2. Kothari, M.L.: Genesis of cancer. A temporal approach. J. Postgrad. Med,1968; 14:48.
3. Huang S, Ingber DE. A non-genetic basis for cancer progression and metastasis: self-organizing attractors in cell regulatory networks. Breast disease. 2007 Jan 1;26(1):27-54.
4. Burnet M. Cancer—a biological approach: I. The processes of control. II. The significance of somatic mutation. British medical journal. 1957 Apr 6;1(5022):779.
5. Rowland JH, Baker F. Introduction: resilience of cancer survivors across the lifespan. Cancer. 2005 Dec 1;104(S11):2543-8.
6. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral oncology. 2009 May 31;45(4):309-16.
7. Cohen, S.S : Introduction to the polyamines. A new method for rapid microscopic diagnosis of tumors, 1971.
8. Cohn MS, Tabor CW, Tabor H. Regulatory mutations affecting ornithine decarboxylase activity in Saccharomyces cerevisiae. J Bacteriol. 1980 Jun;142(3):791-799.
9. Dudgeon, L. S. et al. A new method for rapid microscopic diagnosis of tumors. Br J Surg, 22(4), 1927.
10. Gruner, O.C.: Experience with the Pfeiffer Crystallization method for diagnosis of cancer. J. Cane. Med. Assoc, 1940, 43:99-106.
11. Pegg AE, Williams-Ashman HG. On the role of S-adenosyl-L-methionine in the biosynthesis of spermidine by rat prostate. J Biol Chem. 1969 Feb 25;244(4):682-693.
12. Law J. The development of specialties in science: The case of X-ray protein crystallography. Science Studies. 1973 Jul;3(3):275-303.
13. Mager J. The stabilizing effect of spermine and related polyamines and bacterial protoplasts. Biochem Biophys Acta. 1959 Dec; 36:529-531
14. Alexander Jerome: Colloid Symposium Monograph, 1923.
15. Pfeiffer: Sensitive crystallization process, demonstration formative processes in the blood. Cancaster, Pennsylvania, 1935.
16. Quadeer, A. Crystallization test for detection of malignancy, J. Anat. Soc. Ind. 1980; Vol. 29, No. 2.
17. Quadeer, A. A simple blood test as a diagnostic tool for detection of susceptibility to malignancy. Jr. Anat. Soc. Ind., 1985; Vol. 34, No. 1,pp.33(April85).
18. Gruner, O.C.: Experience with the Pfeiffer Crystallization method for diagnosis of cancer. J. Cane. Med. Assoc, 1940, 43:99-106.
19. Pfeiffer and Miley. The influence of blood of malignant and non-malignant origin upon the crystallization of copper chloride paper read before the 3rd International Congress on Cancer, 1989.
20. Morris D.L., Morris, C.T.: Specific effect of certain tissue extract on the crystallization pattern of cupric chloride. Jour of Phy che, 1939; Vol. 43, 623-629.
21. Prehn, R. T.: Effect of carcinogens on normal cells. In, The Remote Effects of Cancer on the Nervous System. I. (Ed Brain, L, and Norris, F.H.) Grune and Stratton, New York, London, 1964:p. 168.
22. Sabarth, E. and Williams, H.N. Sensitive crystallization processes- A demonstration of formative forces in blood, 2nd edition. Anthroposophic Press, Spring Valley, New York, 1975.
23. Begouin. Quefques resultants data method' dec crystallization de eiffer dans Ie diagnostic due cancer et de la tuberculosis. Bull Scad. Med.(Paris); 1938, 119,46.
24. Menke's, G. Cristallization de la leucine au contact as serums normaux et patho. Arch. Sc. Rent.) 16, 169.
25. Selawry A. Die Kupferchlorid Crystallization, 1957.
How to Cite
Bali S, Marathe RR. Crystallization Test for Early Detection of Malignancy. Int Arch BioMed Clin Res [Internet]. 2017Jun.18 [cited 2019Oct.17];3(2):46-9. Available from: